Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 3Phase 2 2Phase 1/2 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Sexual Infantilism 1Diabetes Mellitus, Type 1 1Craniopharyngioma 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Exenatide × Clear all
NCT00566813 2021-04-06

Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression

University of Illinois at Chicago

Phase 1/2 Completed
10 enrolled 10 charts

Diabetes Mellitus, Type 1

NCT01061775 2019-10-08

Effects of Exenatide on Hypothalamic Obesity

Children's Hospitals and Clinics of Minnesota

Phase 1/2 Completed
19 enrolled 17 charts
CNS

Craniopharyngioma, Sexual Infantilism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡